INTANGIBLE ASSETS, NET - Narrative (Details) |
3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2021
USD ($)
|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2021
USD ($)
|
Dec. 31, 2019
USD ($)
|
Dec. 31, 2018
USD ($)
|
|
Finite-Lived Intangible Assets [Line Items] | ||||||
Amortization of intangible assets | $ 191,000 | $ 191,000 | $ 573,000 | $ 972,000 | ||
Intangible asset impairment | 19,000,000 | $ 0 | 19,000,000 | $ 0 | ||
Licenses | ||||||
Indefinite-lived Intangible Assets [Line Items] | ||||||
Indefinite-lived intangible assets acquired | $ 19,000,000 | |||||
Intangible assets impairment charge | 19,000,000 | 19,000,000 | ||||
Deferred tax liabilities, intangible assets write-off | $ 6,650,000 | $ 6,650,000 | ||||
Licenses | Measurement Input, Weighted Average Cost of Capital | Discounted Future Cash Flow | ||||||
Indefinite-lived Intangible Assets [Line Items] | ||||||
Intangible assets, measurement input | 0.22 | 0.22 | ||||
Herbal Brands, Inc. | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Finite-lived intangible assets acquired | $ 7,075,000 |
X | ||||||||||
- Definition Deferred Tax Liabilities, Intangible Assets Write-Off No definition available.
|
X | ||||||||||
- Definition Intangible Assets, Measurement Input No definition available.
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|